Introduction Stem cell therapy with bone marrow-derived mononuclear cells (BMMCs) is an option for improving joint function in osteonecrosis of the femoral head (ONFH). (bioskinrevive.com)
Thus, we aimed to compare the efficiency of bone marrow mononuclear cells (BMMCs) and mesenchymal stem cells (MSCs) from adipose tissue of Chlorocebus aethiops in induced bone injury. (bvsalud.org)
Flow cytometry analysis showed a significantly higher number of hematopoietic stem/endothelial progenitor cell markers in concentrated BMMCs when compared with bone marrow aspirate indicating an enrichment of these cell types. (bioskinrevive.com)
Mesenchymal stem1
All the studies administered autologous cells, except one that used allogenic adipose-derived mesenchymal stem cells (Allogenic AD-MSC). (springeropen.com)
MSCs4
In an autologous manner, the BMMCs were infused in the right iliac crest, and MSCs from adipose tissue in the left iliac crest. (bvsalud.org)
The best option for treatment of injuries with bone tissue loss in old world primates is to use autologous MSCs from adipose tissue, suggesting we can extrapolate the results to humans, since there is phylogenetic proximity between species. (bvsalud.org)
Assim, objetivou-se comparar a eficiência das células mononucleares de medula óssea (BMMCs) e das células-tronco mesenquimais (MSCs) do tecido adiposo de Chlorocebus aetiops na lesão óssea induzida. (bvsalud.org)
de forma autóloga, as BMMCs foram infundidas na crista ilíaca direita e as MSCs de tecido adiposo na crista ilíaca esquerda. (bvsalud.org)
Patients2
Conclusion The autologous BMMC implantation with a minimally invasive technique resulted in significant pain relief and halted the progression of early stages of ONFH in SCD patients. (bioskinrevive.com)
In summary our results indicate that infusion of BMMCs enriched with stem/progenitor cells is a safe and effective treatment for the early stages of ONFH in SCD patients. (bioskinrevive.com)
Administration2
The purpose of this study was to explore the effect of autologous bone marrow stem cell mobilization induced by intranasal administration of granulocyte-macrophage colony stimulating factor (GM-CSF) for TBI in rats. (uwi.edu)
The present study evaluated the safety of autologous BMDMC administration through bronchoscopy in patients with silicosis over a period of 360 days. (medscape.com)
Recent2
Recent studies have shown that autologous adult stem cells may be a strategy for treatment of traumatic brain injury (TBI) in humans. (uwi.edu)
Recent studies have investigated the impact of either autologous BMDMCs or mesenchymal stem cells (MSCs) on lung diseases. (medscape.com)